IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC)

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 10, 2008, Pages 1059-1065

  Richter, Petra ^a   Junker, Kerstin ^a   Franz, Marcus ^a   Berndt, Angela ^b   Geyer, Christiane ^a   Gajda, Mieczyslaw ^a   Kosmehl, Hartwig ^c   Berndt, Alexander ^a   Wunderlich, Heiko ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

Fibronectin; IIICS region; Invasion; Oncofoetal glycosylation; Urothelial carcinoma of urinary bladder

Indexed keywords

FIBRONECTIN; MESSENGER RNA; ONCOFETAL ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MONITORING; PAPILLOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; TISSUE DISTRIBUTION; URINE; UROTHELIUM; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; FEMALE; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 50249117650     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0390-6     Document Type: Article

References (35)

1. Y Abe NA Bui-Thanh CM Ballantyne AR Burns 2005 Extra domain A and type III connecting segment of fibronectin in assembly and cleavage Biochem Biophys Res Commun 338 1640 1647
2. JM Crane BA Armson L Dodds RF Feinberg W Kennedy SA Kirkland 1999 Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery Obstet Gynecol 93 517 522
3. A Di Carlo D Terracciano A Mariano V Macchia 2005 Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions Int J Oncol 26 1363 1368
4. O Driemel A Berndt A Hartmann UD Mueller-Richter R Bauer TE Reichert H Kosmehl 2006 [Clinical and immunohistochemical findings of intra- and extraoral angiosarcomas.] Mund Kiefer Gesichtschir 10 239 247
5. Eble JN, Sauter G, Epstein JE, Sesterhenn IA (2004) World Health Organization classification of tumours. Pathology and genetics of male genital organs. IARC Press, Lyon
6. S Eissa M Swellam M Sadek MS Mourad O El Ahmady A Khalifa 2002 Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors J Urol 168 465 469
7. A Hegele A Heidenreich Z Varga R von Knobloch P Olbert J Kropf R Hofmann 2003 Cellular fibronectin in patients with transitional cell carcinoma of the bladder Urol Res 30 363 366
8. W Hindermann A Berndt KM Haas H Wunderlich D Katenkamp H Kosmehl 2003 Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis Cancer Detect Prev 27 109 115
9. H Inufusa M Nakamura T Adachi Y Nakatani K Shindo M Yasutomi H Matsuura 1995 Localization of oncofetal and normal fibronectin in colorectal cancer. correlation with histologic grade, liver metastasis, and prognosis Cancer 75 2802 2808
10. E Ioachim M Michael NE Stavropoulos E Kitsiou M Salmas V Malamou-Mitsi 2005 A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma BJU Int 95 655 659
11. J Kaczmarek P Castellani G Nicolo B Spina G Allemanni L Zardi 1994 Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues Int J Cancer 59 11 16
12. M Katayama K Kamihagi K Nakagawa T Akiyama Y Sano R Ouchi S Nagata F Hino I Kato 1993 Increased fragmentation of urinary fibronectin in cancer patients detected by immunoenzymometric assay using domain-specific monoclonal antibodies Clin Chim Acta 217 115 128
13. H Kosmehl A Berndt D Katenkamp 1996 Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects Virchows Arch 429 311 322
14. LA Liotta 1986 Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture Cancer Res 46 1 7
15. MA Liz MM Sousa 2005 Deciphering cryptic proteases Cell Mol Life Sci 62 989 1002
16. B Loridon-Rosa P Vielh H Matsuura H Clausen C Cuadrado P Burtin 1990 Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections Cancer Res 50 1608 1612
17. U Mandel M Hamilton Therkildsen J Reibel B Sweeney H Matsuura S Hakomori E Dabelsteen H Clausen 1992 Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies Apmis 100 817 826
18. U Mandel B Gaggero J Reibel MH Therkildsen E Dabelsteen H Clausen 1994 Oncofetal fibronectins in oral carcinomas: correlation of two different types APMIS 102 695 702
19. H Matsuura S Hakomori 1985 The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma Proc Natl Acad Sci USA 82 6517 6521
20. V Menendez A Fernandez-Suarez JA Galan M Perez F Garcia-Lopez 2005 Diagnosis of bladder cancer by analysis of urinary fibronectin Urology 65 284 289
21. AW Menzin JR de Loret Mola WB Bilker JE Wheeler SC Rubin RF Feinberg 1998 Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants Cancer 82 152 158
22. JC Morrison JR Allbert BN McLaughlin NS Whitworth WE Roberts RW Martin 1993 Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery Am J Obstet Gynecol 168 538 542
23. I Putz M Winkler W Rath 1995 [Reliability of the detection of fetal fibronectin using monoclonal antibody FDC-6] Geburtshilfe Frauenheilkd 55 703 706
24. D Raghavan R Huben 1995 Management of bladder cancer Curr Probl Cancer 19 1 64
25. M Sanchez-Carbayo M Urrutia JM de Gonzalez Buitrago JA Navajo 2000 Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer Clin Cancer Res 6 3585 3594
26. AJ Santas JA Peterson JL Halbleib SE Craig MJ Humphries DM Peters 2002 Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading J Biol Chem 277 13650 13658
27. M Tajiri S Yoshida Y Wada 2005 Differential analysis of site-specific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment Glycobiology 15 1332 1340
28. T Takano A Miyauchi T Yokozawa F Matsuzuka I Maeda K Kuma N Amino 1999 Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA Cancer Res 59 4542 4545
29. T Turpeenniemi-Hujanen RF Feinberg A Kauppila U Puistola 1995 Extracellular matrix interactions in early human embryos: implications for normal implantation events Fertil Steril 64 132 138
30. K Vibe-Pedersen S Magnusson FE Baralle 1986 Donor and acceptor splice signals within an exon of the human fibronectin gene: a new type of differential splicing FEBS Lett 207 287 291
31. HH Wandall S Dabelsteen JA Sorensen A Krogdahl U Mandel E Dabelsteen 2006 Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: The production of glycosylated onco-foetal fibronectin by carcinoma cells. Oral Oncol 43 301 309
32. UM Warawdekar SM Zingde KS Iyer P Jagannath AR Mehta NG Mehta 2006 Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients Clin Chim Acta 372 83 93
33. CB Wilson J Leopard DA Cheresh RM Nakamura 1996 Extracellular matrix and integrin composition of the normal bladder wall World J Urol 14 Suppl 1 S30 S37
34. JA Witjes R Umbas FM Debruyne JA Schalken 1995 Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer J Urol 154 2185 2189
35. H Wunderlich O Reichelt DH Zermann J Schubert A Berndt H Kosmehl 2001 Fetal fibronectin: a new screening-marker for bladder cancer? Oncol Rep 8 669 672